These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12428861)

  • 1. D-penicillamine induced polymyositis and morphea in a woman with Hashimoto thyroiditis.
    Dourmishev LA; Stomonjakova SR; Dourmishev AL
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):538-9. PubMed ID: 12428861
    [No Abstract]   [Full Text] [Related]  

  • 2. Postural changes, dysphagia, and systemic sclerosis.
    Barrera P; den Broeder AA; van den Hoogen FH; van Engelen BG; van de Putte LB
    Ann Rheum Dis; 1998 Jun; 57(6):331-8. PubMed ID: 9771206
    [No Abstract]   [Full Text] [Related]  

  • 3. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphea-like reaction to D-penicillamine therapy.
    Bernstein RM; Hall MA; Gostelow BE
    Ann Rheum Dis; 1981 Feb; 40(1):42-4. PubMed ID: 6451203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine.
    Ahn JH; Kim TH; Peck KR; Song YW
    Korean J Intern Med; 1993 Jan; 8(1):46-50. PubMed ID: 8268147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine.
    Boehler A; Vogt P; Speich R; Weder W; Russi EW
    Eur Respir J; 1996 Jun; 9(6):1317-9. PubMed ID: 8804954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease.
    Atzori L; Ferreli C; Agosta D; Mou M; Coni P; Lachowicz JI; Pilloni L
    Int J Dermatol; 2023 Feb; 62(2):246-249. PubMed ID: 35968714
    [No Abstract]   [Full Text] [Related]  

  • 8. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
    Shapiro M; Jimenez S; Werth VP
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
    Derk CT; Jimenez SA
    J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyositis due to D-penicillamine in a patient with systemic sclerosis.
    Santos JC; Velasco JA
    Clin Exp Dermatol; 1991 Jan; 16(1):76. PubMed ID: 2025947
    [No Abstract]   [Full Text] [Related]  

  • 12. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody.
    Jenkins EA; Hull RG; Thomas AL
    Br J Rheumatol; 1993 Dec; 32(12):1109-10. PubMed ID: 8252325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-penicillamine induced polymyositis causing complete heart block.
    Wright GD; Wilson C; Bell AL
    Clin Rheumatol; 1994 Mar; 13(1):80-2. PubMed ID: 8187449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of myasthenia gravis caused by D-penicillamine therapy].
    Susa S; Akiba J; Kurimura M; Kurita K; Daimon M; Manaka H; Yamatani K; Kato T
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2513-5. PubMed ID: 9922674
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine.
    Zvulunov A; Grunwald MH; Avinoach I; Halevy S
    Int J Dermatol; 1997 Jun; 36(6):476-7. PubMed ID: 9248901
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y; Kohriyama K; Matsui T
    J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of vitiligo, morphea, and Hashimoto's thyroiditis.
    Dervis E; Acbay O; Barut G; Karaoglu A; Ersoy L
    Int J Dermatol; 2004 Mar; 43(3):236-7. PubMed ID: 15009403
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progressive systemic sclerosis with pancytopenia, polymyositis and complete heart block developing after D-penicillamine therapy: a case report].
    Matsumura T; Kabashima T; Kono I; Yamane K; Sakurai T; Yamaguchi I; Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1985 Jul; 74(7):958-63. PubMed ID: 4056558
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
    Nishikai M; Funatsu Y; Homma M
    Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary involvement in systemic sclerosis due to therapy and as a complication.
    Chiappini F; Zoli A; Maugeri L
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):111-3. PubMed ID: 16128227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.